# Evaluation of Immune Response in COVID-19 Patients

> **NCT04438629** · — · UNKNOWN · sponsor: **Azienda Ospedaliera Universitaria Integrata Verona** · enrollment: 80 (estimated)

## Conditions studied

- Allergy and Immunology
- Infection Viral

## Interventions

- **DRUG:** COVID-19 treatment

## Key facts

- **NCT ID:** NCT04438629
- **Lead sponsor:** Azienda Ospedaliera Universitaria Integrata Verona
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-26
- **Primary completion:** 2020-06-10
- **Final completion:** 2020-11-26
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04438629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04438629, "Evaluation of Immune Response in COVID-19 Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04438629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*